Found 33 matching trials
T-Lymphocytes for Prevention or Treatment of Viral Infections Following Hematopoietic Stem Cell Transplantation
PHASE1This Phase I dose-escalation trial is designed to evaluate the safety of ra...
Status
Active Not Recruiting
Location
Childrens National Medical Center
Donor Cytomegalovirus-Specific Cytotoxic T-Lymphocytes in Treating Patients With a Persistent Cytomegalovirus Infection
PHASE2This phase II trial studies how well donor cytomegalovirus-specific cytotox...
Status
Active Not Recruiting
Location
M D Anderson Cancer Center
CMV-CTL for the Treatment of CMV Infection After HSCT
PHASE4Human cytomegalovirus (CMV) infection is a major cause of morbidity and mor...
Location
Shanghai Jiao Tong University Affilated Shanghai General Hospital
CD19 CAR T Cells for B Cell Malignancies After Allogeneic Transplant
PHASE1This phase I/II trial studies the safety and toxicity of post-transplant tr...
Location
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium
Study of Posoleucel (ALVR105,Viralym-M) for Multi-Virus Prevention in Patients Post-Allogeneic Hematopoietic Cell Transplant
PHASE2This is a Phase 3 study to evaluate posoleucel (ALVR105, Viralym-M); an all...
Location
University of Alabama at Birmingham Children's of Alabama
Most Closely Human Leukocyte Antigen (HLA)-Matched CMV-specific T Lymphocytes (Viralym-C)
PHASE1Patients enrolled on this study will have received a stem cell transplant. ...
Location
Texas Childrens Hospital
T Lymphocytes for the Treatment of AdV, CMV, EBV, BKV and Aspergillus Fumigatus Infections After Allogeneic Stem Cell Transplantation
PHASE1The purpose of the study is to determine the feasibility, safety and effica...
Location
University General Hospital of Patras
A Study Using Allogenic-Cytomegalovirus (CMV) Specific Cells for Glioblastoma Multiforme (GBM)
PHASE1The primary purpose of this study is to determine the safety and efficacy o...
Location
Multiple Locations
Association of T Gamma Delta-CD16+ Cells and Anti-CMV Immunoglobulins in the Prevention of CMV Infection
PHASE2CMV infection in transplantation remains the most frequent infectious compl...
Location
Hopital Pellegrin
Autologous Cytomegalovirus (CMV) Specific CD8+ T Cells as Treatment for CMV Reactivation
PHASE1The investigators will assess whether the infusion of autologous CMV-specif...
Location
Hammersmith Hospital